Related Experiment Videos

Growth factor gene expression in kidney of murine polycystic kidney disease

T Nakamura1, I Ebihara, I Nagaoka

  • 1Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan.

Insights

Kidney disease in DBA/2FG-pcy mice shows increased growth-related gene expression, including proliferating cell nuclear antigen (PCNA) and transforming growth factor-beta (TGF-beta). These changes may drive the progression of polycystic kidney disease.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Genetics

Background:

  • The DBA/2FG-pcy mouse model exhibits a slowly progressive kidney disease.
  • This condition shares similarities with human autosomal dominant polycystic kidney disease (ADPKD).

Purpose of the Study:

  • To investigate the mRNA expression of key growth-related proteins in the kidneys of DBA/2FG-pcy mice.
  • To compare gene expression patterns between affected mice and control DBA/2 mice at different ages (8, 16, and 30 weeks).

Main Methods:

  • Quantitative analysis of mRNA levels using techniques such as RT-PCR or similar methods.
  • Comparison of gene expression profiles in kidney tissues from DBA/2FG-pcy and DBA/2 mice at specified time points.

Main Results:

  • Elevated mRNA expression of proliferating cell nuclear antigen (PCNA), transforming growth factor-beta (TGF-beta), platelet-derived growth factor (PDGF)-A and -B chains, insulin-like growth factor (IGF)-I, and basic fibroblast growth factor (bFGF) was observed.
  • At 30 weeks, these genes showed significant increases (3.7 to 5.4-fold) in DBA/2FG-pcy mice compared to controls.
  • Conversely, epidermal growth factor (EGF) mRNA levels decreased with age in DBA/2FG-pcy mice.

Conclusions:

  • The observed downregulation of EGF and upregulation of PCNA, TGF-beta, PDGF, IGF-I, and bFGF mRNA likely contribute to the development and progression of kidney cysts in DBA/2FG-pcy mice.
  • These findings offer insights into the molecular mechanisms underlying polycystic kidney disease.
  • The study highlights potential therapeutic targets for managing kidney disease progression.

Related Concept Videos